Volume 21 - Number 4
July/August 2005
pg 191
Exenatide: A Novel Therapeutic Approach for Type 2 Diabetes Mellitus
Amie D McCordThis article is approved for continuing education credit.
pg 197
Atorvastatin: An Update of Recent Clinical Trial Experience
Philip M Mendys and Ross J Simpson JrThis article is approved for continuing education credit.
Long-Acting Angiotensin-Converting Enzyme Inhibitors in Congestive Heart Failure: Does Multiple-Daily Dosing Provide Additional Benefit Over Once-Daily Dosing?
Myra T Belgeri
Factors Associated with Ribavirin-Induced Anemia
Frank K Friedenberg, Satya P Gollamudi, Alan W Chang, Manjushree Guatam, Joan K Schmutz, Kevin S Skole, Rebecca M Thomas, and Martin Black
Argatroban in Post-Cardiovascular Surgery Patient with Heparin-Induced Thrombocytopenia Requiring Hemodialysis and Continuous Hemofiltration
Keith K Lau, Eric J Escue, Bettina H Ault, Deborah P Jones, and Stephanie A Storgion
pg 244
Medical Problems: Brief Reviews Atrial Fibrillation
Michael J Katz
190
Test Your Knowledge
218
Therapeutic Trends
222
What's New
225
From the Literature
227
Pharmacy Focus
230
From the States
232
Calendar of Events
233
Compounding Formulations
234
New Publications
237
PharmaCE Test Questions
the journal of Pharmacy Technology is published by HARVEY WHITNEY BOOKS COMPANY 8044 Montgomery Road, Suite 415, Cincinnati, OH 45236-2919 P.O. Box 42696, Cincinnati, OH 45242-0696 USA Tel. 513/793-3555, FAX 513/793-3600Office Hours: 9-5 E.S.T. Contact Information All Rights Reserved. Copyright © 1998-